Bank of Nova Scotia’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-297,009
Closed -$34.4M 1069
2023
Q3
$34.4M Sell
297,009
-235,491
-44% -$27.2M 0.09% 173
2023
Q2
$54.8M Sell
532,500
-369,810
-41% -$38M 0.14% 114
2023
Q1
$98.5M Buy
902,310
+684,167
+314% +$74.7M 0.29% 63
2022
Q4
$24.8M Sell
218,143
-1,380,115
-86% -$157M 0.06% 207
2022
Q3
$98.9M Buy
1,598,258
+1,092,981
+216% +$67.6M 0.31% 53
2022
Q2
$40.3M Buy
505,277
+124,076
+33% +$9.9M 0.1% 182
2022
Q1
$40.1M Buy
381,201
+156,663
+70% +$16.5M 0.07% 232
2021
Q4
$24.2M Buy
224,538
+127,484
+131% +$13.7M 0.03% 334
2021
Q3
$10.6M Buy
+97,054
New +$10.6M 0.02% 430